SALL4 and cholangiocarcinoma: Zhu et al. demonstrated that increased SALL4 was associated with poor prognosis in CCA patients and induced malignant phenotypes of CCA by regulating PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways and promoting the EMT process [32].